LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Speech and Body Movement in Parkinson Disease

Cynthia Fox, Georg Ebersbach, Lorraine O. Ramig, Shimon Sapir

Parkinson s Disease · 2012 · 172 citations · 90 references

DOIFull text

Open access

Concepts

TL;DR

Exercise‑based behavioral treatments may improve function and slow motor symptom progression in Parkinson disease, and the LSVT programs have evolved over 20 years to target speech and limb motor systems. This paper offers an integrative discussion of the LSVT programs, covering their rationale, efficacy evidence, limitations, and future research directions. The LSVT programs uniquely combine amplitude‑increasing targets, sensory recalibration, self‑cueing training, and intensive delivery to promote activity‑dependent neuroplasticity and motor learning.

Abstract

Recent advances in neuroscience have suggested that exercise-based behavioral treatments may improve function and possibly slow progression of motor symptoms in individuals with Parkinson disease (PD). The LSVT (Lee Silverman Voice Treatment) Programs for individuals with PD have been developed and researched over the past 20 years beginning with a focus on the speech motor system (LSVT LOUD) and more recently have been extended to address limb motor systems (LSVT BIG). The unique aspects of the LSVT Programs include the combination of (a) an exclusive target on increasing amplitude (loudness in the speech motor system; bigger movements in the limb motor system), (b) a focus on sensory recalibration to help patients recognize that movements with increased amplitude are within normal limits, even if they feel “too loud” or “too big,” and (c) training self-cueing and attention to action to facilitate long-term maintenance of treatment outcomes. In addition, the intensive mode of delivery is consistent with principles that drive activity-dependent neuroplasticity and motor learning. The purpose of this paper is to provide an integrative discussion of the LSVT Programs including the rationale for their fundamentals, a summary of efficacy data, and a discussion of limitations and future directions for research.

References

90